Jacquelyn Sumer

Jacquelyn Sumer has a long and varied work experience, beginning in 2003 as an Associate at Kaye Scholer LLP. In 2005, they became a Law Clerk at the United States District Court, District of Columbia. Jacquelyn returned to Kaye Scholer LLP in 2006 as an Associate. In 2010, they moved to Novartis as an Executive Director, Pharmaceuticals Counsel. In 2017, they joined Celgene as an Executive Director, Head CAR T Legal and Executive Director, Sr. Corp. Counsel, Hematology/Oncology Franchise. In 2019, they moved to Bristol-Myers Squibb as Vice President and Assistant General Counsel, Worldwide Hematology and Cell Therapy. In 2021, they joined Genocea as Chief Legal and Compliance Officer. Most recently, in 2022, they became Chief Legal Officer, Corporate Secretary, and Chief Compliance Officer at Cullinan Oncology.

Jacquelyn Sumer completed their Bachelor's degree in International Relations and Affairs from Bucknell University between 1995 and 1999. Jacquelyn then attended Duke University School of Law, earning a Doctor of Law (JD) and a Master of Laws (LL.M.) in International Law and Legal Studies between 2000 and 2003.